These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 11571011)
1. The acceptability of HIV immunization: examining vaccine characteristics as determining factors. Liau A; Zimet GD AIDS Care; 2001 Oct; 13(5):643-50. PubMed ID: 11571011 [TBL] [Abstract][Full Text] [Related]
2. Preventive HIV vaccine acceptability and behavioral risk compensation among high-risk men who have sex with men and transgenders in Thailand. Newman PA; Roungprakhon S; Tepjan S; Yim S Vaccine; 2010 Jan; 28(4):958-64. PubMed ID: 19925897 [TBL] [Abstract][Full Text] [Related]
3. Determinants of personal demand for an AIDS vaccine in Uganda: contingent valuation survey. Bishai D; Pariyo G; Ainsworth M; Hill K Bull World Health Organ; 2004 Sep; 82(9):652-60. PubMed ID: 15628202 [TBL] [Abstract][Full Text] [Related]
4. The private demand for an AIDS vaccine in Thailand. Suraratdecha C; Ainsworth M; Tangcharoensathien V; Whittington D Health Policy; 2005 Mar; 71(3):271-87. PubMed ID: 15694496 [TBL] [Abstract][Full Text] [Related]
5. Vaccine characteristics and acceptability of HIV immunization among adolescents. Zimet GD; Blythe MJ; Fortenberry JD Int J STD AIDS; 2000 Mar; 11(3):143-9. PubMed ID: 10726935 [TBL] [Abstract][Full Text] [Related]
6. The potential global market size and public health value of an HIV-1 vaccine in a complex global market. Marzetta CA; Lee SS; Wrobel SJ; Singh KJ; Russell N; Esparza J Vaccine; 2010 Jul; 28(30):4786-97. PubMed ID: 20471439 [TBL] [Abstract][Full Text] [Related]
7. Parental attitudes about sexually transmitted infection vaccination for their adolescent children. Zimet GD; Mays RM; Sturm LA; Ravert AA; Perkins SM; Juliar BE Arch Pediatr Adolesc Med; 2005 Feb; 159(2):132-7. PubMed ID: 15699306 [TBL] [Abstract][Full Text] [Related]
8. Knowledge and attitudes regarding preventative HIV vaccine clinical trials in Italy: results of a national survey. Starace F; Wagner TM; Luzi AM; Cafaro L; Gallo P; Rezza G AIDS Care; 2006 Jan; 18(1):66-72. PubMed ID: 16282079 [TBL] [Abstract][Full Text] [Related]
9. Feasibility of northern Thai factory workers as participants in HIV vaccine trials. Natpratan C; Nantakwang D; Beyrer C; Kunawararak P; Gunhom C; Celentano DD; Nelson KE; Khamboonruang C Southeast Asian J Trop Med Public Health; 1996 Sep; 27(3):457-62. PubMed ID: 9185253 [TBL] [Abstract][Full Text] [Related]
10. Community heroes or "high-risk" pariahs? Reasons for declining to enroll in an HIV vaccine trial. Newman PA; Daley A; Halpenny R; Loutfy M Vaccine; 2008 Feb; 26(8):1091-7. PubMed ID: 18237829 [TBL] [Abstract][Full Text] [Related]
11. Household demand for preventive HIV/AIDS vaccines in Thailand: do husbands' and wives' preferences differ? Whittington D; Suraratdecha C; Poulos C; Ainsworth M; Prabhu V; Tangcharoensathien V Value Health; 2008; 11(5):965-74. PubMed ID: 18194396 [TBL] [Abstract][Full Text] [Related]
12. Undergraduates' perception of HIV immunization: attitudes and behaviours as determining factors. Liau A; Zimet GD Int J STD AIDS; 2000 Jul; 11(7):445-50. PubMed ID: 10919486 [TBL] [Abstract][Full Text] [Related]
13. Predictors of STI vaccine acceptability among parents and their adolescent children. Zimet GD; Perkins SM; Sturm LA; Bair RM; Juliar BE; Mays RM J Adolesc Health; 2005 Sep; 37(3):179-86. PubMed ID: 16109336 [TBL] [Abstract][Full Text] [Related]
14. Attitudes about human immunodeficiency virus immunization: the influence of health beliefs and vaccine characteristics. Liau A; Zimet GD; Fortenberry JD Sex Transm Dis; 1998 Feb; 25(2):76-81. PubMed ID: 9518382 [TBL] [Abstract][Full Text] [Related]
15. Willingness to participate in HIV vaccine trials among HIV-negative gay men in Sydney, Australia. Van de Ven P; Mao L; Crawford J; Prestage G; Grulich A; Kaldor J; Kippax S Int J STD AIDS; 2005 Apr; 16(4):314-7. PubMed ID: 15899086 [TBL] [Abstract][Full Text] [Related]
16. The impact of an AIDS vaccine in developing countries: a new model and initial results. Stover J; Bollinger L; Hecht R; Williams C; Roca E Health Aff (Millwood); 2007; 26(4):1147-58. PubMed ID: 17630459 [TBL] [Abstract][Full Text] [Related]
17. Demographic and AIDS-related characteristics of consenters to a population-based HIV-survey: results from a pilot study in Arusha, Tanzania. Ole-King'Ori N; Klepp KI; Kissila PE; Biswalo PM; Mnyika KS East Afr Med J; 1994 Aug; 71(8):483-9. PubMed ID: 7867536 [TBL] [Abstract][Full Text] [Related]
18. HIV risk and prevention in a post-vaccine context. Newman PA; Duan N; Rudy ET; Johnston-Roberts K Vaccine; 2004 May; 22(15-16):1954-63. PubMed ID: 15121308 [TBL] [Abstract][Full Text] [Related]
19. Patients' high acceptability of a future therapeutic HIV vaccine in France: a French paradox? Dimi S; Zucman D; Chassany O; Lalanne C; Prazuck T; Mortier E; Majerholc C; Aubin-Auger I; Verger P; Duracinsky M BMC Infect Dis; 2019 May; 19(1):401. PubMed ID: 31072394 [TBL] [Abstract][Full Text] [Related]
20. Perceived influence of an HIV vaccine on sexual-risk behaviour in the Dominican Republic. Barrington C; Moreno L; Kerrigan D Cult Health Sex; 2008 May; 10(4):391-401. PubMed ID: 18484381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]